Randomized controlled trial2025Industry fundedOpen access

Funded in part by Taisho Toyama Pharmaceutical Company, Taisho Pharmaceutical Co., Ltd., Taisho Pharmaceutical (Japan)

The Effects of Creatine Monohydrate Supplementation on Recovery from Eccentric Exercise-Induced Muscle Damage: A Double-Blind, Randomized, Placebo-Controlled Trial Considering Sex and Age Differences

Yamaguchi S, Inami T, Nishioka T, Morito A, Ishiyama K, Murayama M

Nutrients · 3 citations

Review labels

Industry funded

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Industry funded
University or hospital
Keio University
Company
Taisho Toyama Pharmaceutical Company
Company
Taisho Pharmaceutical Co., Ltd.
Company
Taisho Pharmaceutical (Japan)
Grants
Taisho Toyama Pharmaceutical Company (H11PA22111)

Based on 4 listed funder(s) and full-text disclosure statement.

Publication

Published
2025-05-23 · Nutrients · vol. 17 · issue 11 · p. 1772
Publisher
Multidisciplinary Digital Publishing Institute
Cited
10 citations · more than 94% of similar papers · 4.3× the field average
Impact
Top 10% most cited in its field
References
39 works
Access
Open access (journal) · CC-BY
Research areas
Exercise and Physiological Responses · Muscle metabolism and nutrition · Sports Performance and Training
Keywords
Delayed onset muscle soreness, Medicine, Placebo, Eccentric, Creatine, Creatine Monohydrate, myalgia, Randomized controlled trial, Physical therapy, Population, Muscle damage, Placebo-controlled study, Eccentric exercise, Muscle fatigue, Internal medicine, Physical medicine and rehabilitation, Double blind, Electromyography
MeSH
muscle, skeletal, humans, creatine, exercise, double-blind method, age factors, sex factors, recovery of function, muscle fatigue, muscle contraction, dietary supplements, adult, female, male, young adult, myalgia

6 authors

From JP

  • Shota YamaguchiKeio University
  • Takayuki Inami · correspondingKeio University
  • Takuya NishiokaKeio University
  • Akihisa MoritoTaisho Pharmaceutical (Japan)
  • Kaho IshiyamaTaisho Pharmaceutical (Japan)
  • Mitsuyoshi MurayamaKeio University

Abstract

Background/Objectives: In this study, we aimed to examine the effect of creatine monohydrate (CrM) supplementation on recovery from eccentric exercise-induced muscle damage (EIMD) in diverse populations, including different sexes and age groups. EIMD decreases maximal voluntary contraction (MVC), restricts the range of motion (ROM), and increases muscle stiffness and delayed-onset muscle soreness, all of which negatively impact athletic performance. Therefore, developing effective recovery strategies is essential. Methods: A double-blind, randomized, placebo-controlled trial was conducted with 40 healthy male and female participants. After 33 days of supplementation with either CrM or placebo (crystalline cellulose), the participants performed eccentric exercises. Recovery indices, including MVC, muscle stiffness, subjective muscle extensive soreness, fatigue, and upper arm circumference, were measured at baseline, immediately after exercise, 48 h post-exercise, and 96 h post-exercise. Results: The creatine supplementation group (CRE) demonstrated a significantly quicker recovery of MVC than the placebo group (PLA). Furthermore, reductions in shear modulus and muscle fatigue were observed in the CRE group. Notably, females in the CRE group exhibited a significant suppression of post-exercise edema, suggesting a sex-specific response. Conclusions: These findings indicate that CrM supplementation may enhance recovery from EIMD, contributing to the maintenance of muscle function and the reduction of discomfort after exercise. CrM has the potential to serve as a practical nutritional strategy to promote recovery, not only for athletes, but also for a broader population.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.